Clinical Trial Update: Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tapentadol prolonged release with oxycodone/naloxone prolonged release in adults with severe chronic low back pain with a neuropathic co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Neuropathic Pain

Drugs mentioned

• Oxycodone/naloxone prolonged release (oxycodone/naloxone)
• Tapentadol prolonged-release (tapentadol)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Back Pain, Low Back Pain | Phase 4 | Status: COMPLETED | Results posted: 2015-06-08